AR037493A1 - Proceso para la preparacion de hidrobromuro de citalopram - Google Patents

Proceso para la preparacion de hidrobromuro de citalopram

Info

Publication number
AR037493A1
AR037493A1 ARP020102723A ARP020102723A AR037493A1 AR 037493 A1 AR037493 A1 AR 037493A1 AR P020102723 A ARP020102723 A AR P020102723A AR P020102723 A ARP020102723 A AR P020102723A AR 037493 A1 AR037493 A1 AR 037493A1
Authority
AR
Argentina
Prior art keywords
citalopram
preparation
hydrobromide
citalopram hydrobromide
formula
Prior art date
Application number
ARP020102723A
Other languages
English (en)
Inventor
Swargam Sathyanarayana
Velayudhan Nair Gopa Kumar
Tarun Kant Sharma
Sujay Biswas
Bakthavathsalan Vijayaraghavan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR037493A1 publication Critical patent/AR037493A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)

Abstract

Proceso industrialmente ventajoso para la preparación de hidrobromuro de citalopram puro de fórmula 1, el cual comprende: i) convertir el citalopram crudo en el correspondiente carbamoilftalano-5 de la fórmula 2, y ii) hacerlo reaccionar con un agente deshidratante para obtener el citalopram que se convierte en su sal de hidrobromuro. El hidrobromuro de citalopram puede contener menos de 0,2% de citalopram desciano
ARP020102723A 2001-07-19 2002-07-19 Proceso para la preparacion de hidrobromuro de citalopram AR037493A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN779DE2001 IN192057B (es) 2001-07-19 2001-07-19

Publications (1)

Publication Number Publication Date
AR037493A1 true AR037493A1 (es) 2004-11-17

Family

ID=11097086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102723A AR037493A1 (es) 2001-07-19 2002-07-19 Proceso para la preparacion de hidrobromuro de citalopram

Country Status (7)

Country Link
US (1) US20040254385A1 (es)
EP (1) EP1412340A4 (es)
AR (1) AR037493A1 (es)
AU (1) AU2002317420A1 (es)
CA (1) CA2454335A1 (es)
IN (1) IN192057B (es)
WO (1) WO2003007872A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5095615B2 (ja) 2005-06-27 2012-12-12 バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ ブプロピオン塩の放出調整製剤
BRPI0814556A2 (pt) * 2007-07-10 2015-01-06 Thomson Licensing Método para determinar automaticamente um grupo de pares localizados próximo a outro par em uma rede de comunicação e servidor associado, dispositivo de análise e dispositivo de comunicação
PE20091156A1 (es) * 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
EP2595979B1 (en) 2010-07-23 2016-04-06 H. Lundbeck A/S Process for the purification of pharmaceutically acceptable salts of escitalopram
CN103936702A (zh) * 2014-05-07 2014-07-23 成都诺维尔生物医药有限公司 艾司西酞普兰杂质j的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
CZ291440B6 (cs) * 1997-07-08 2003-03-12 H. Lundbeck A/S Způsob výroby citalopramu
AR032455A1 (es) * 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva

Also Published As

Publication number Publication date
WO2003007872A3 (en) 2003-10-23
EP1412340A2 (en) 2004-04-28
CA2454335A1 (en) 2003-01-30
WO2003007872A2 (en) 2003-01-30
IN192057B (es) 2004-02-14
US20040254385A1 (en) 2004-12-16
EP1412340A4 (en) 2004-12-01
AU2002317420A1 (en) 2003-03-03

Similar Documents

Publication Publication Date Title
AR020573A1 (es) Metodo para la preparacion de citalopram
ES2149734T3 (es) Metodo para la preparacion de citalopram.
ES2195970T3 (es) L-ribavirina y usos de la misma.
EA200300337A1 (ru) Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
ES2103751T3 (es) Procedimiento para la obtencion de oxetanonas.
CY1109989T1 (el) 3,4-di-υποκαθισταμενες cyclobutene-1,2-diones ως συνδετες του υποδοχεα των cxc-χημειοκινων
EA200702562A1 (ru) Способ получения хлоргидрина путем конверсии полигидроксилированных алифатических углеводородов
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
CL2008002673A1 (es) Procedimiento se preparacion de citalopram que comprende hacer reaccionar un compuesto derivado de benzofurano con un agente eshidratante y una sulfonamida (div. sol. 2003-01).
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
AR030682A1 (es) COMPOSICIONES QUE CONTIENEN POLICARBONATO , PROCEDIMIENTO PARA SU PRODUCCIoN, EMPLEO DE DICHAS COMPOSICIONES PARA LA FABRICACIoN DE CUERPOS MOLDEADOS O DE PIEZAS MOLDEADAS DE CUALQUIER TIPO, CUERPOS MOLDEADOS O PIEZAS MOLDEADAS OBTENIBLES A PARTIR DE DICHAS COMPOSICIONES.
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
AR087007A2 (es) Proceso para preparar un derivado tiazolico intermediario en la sintesis de pesticidas de guanidina
AR008539A1 (es) PROCESO PARA LA PREPARACIoN DE DERIVADOS DE TIAZOL, INTERMEDIARIOS DEL MISMO Y PROCEDIMENTO PARA LA PREPARACIoN DE INTERMEDIARIOS
AR037493A1 (es) Proceso para la preparacion de hidrobromuro de citalopram
CY1109761T1 (el) Εντομοαπωθητικο μεσο
EA200100853A1 (ru) Резорциновая композиция
WO2002096546A8 (de) Tensidgemisch
EA200200162A1 (ru) Способ деацилирования липодепсипептидов
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
WO2003000016A3 (en) Highly concentrated organic compound emulsions and methods of use
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona

Legal Events

Date Code Title Description
FA Abandonment or withdrawal